For 2012, The BPI Conference and Exhibition returns to Providence, RI and the Rhode Island Convention Center () For 2012, The BPI Conference and Exhibition returns to Providence, RI and the Rhode Island Convention Center () For 2012, The BPI Conference and Exhibition returns to Providence, RI and the Rhode Island Convention Center () For 2012, The BPI Conference and Exhibition returns to Providence, RI and the Rhode Island Convention Center () For 2012,…
Author Archives: BPI Contributor
The Votes Are In!
On 15 August 2012 BioProcess International announced the 36 finalists for the 2012 BioProcess International Awards — Honoring a Decade of BioProcess. Finalists were determined through an independent judging process, and the results were tabulated and certified by Deloitte & Touche, LLC. To view the names of the finalists and descriptions of their industry contributions, please visit http://awards.bioprocessintl.com/finalists — or read the special 20-page award finalist insert in BioProcess International’s September supplement, The Official Pre-Event Planner of the BPI Conference…
Poster Presentations
Enhancing Manufacturing Development Efficiency Svetlana Dukleska (Merck) Early Research Stability Studies Can Aid in Rapid Screening of Potential Drug Candidates In a competitive research and development (R&D) space with tight time lines, it is important to have a toolbox of extended characterization and analytical assays for rapid screening of potential candidates. Additionally, early research stability studies can provide initial information on potential degradation pathways for screening candidates, for purification development, and for establishing stable formulations. Herein, we show…
Global Marketplace
Product Development Service: Contract development and manufacturing Applications: Clinical- and commercial-scale complex biologics Features: Therapure Biopharma specializes in biologics development, scale-up, and manufacturing. At its 130,000-ft2 CGMP facility in Toronto, Ontario, Canada, the company offers cell-line, process, and analytical development; product manufacturing and testing; and aseptic fill–finish and lyophilization. It has >20 years of experience working with mammalian and primary cell cultures, whole blood, and plasma sources. Contact Therapure Biopharma www.therapurebio.com Capsule Filters Product: CM…
BioProcess International Conference and Exhibition
Expand your knowledge with unparalleled access to new, unpublished data and exclusive case studies from companies of all sizes and perspectives at the most comprehensive event for those directly involved with improving the speed, cost, and quality of developing and manufacturing biotherapeutics. This event will help you improve manufacturing and development efficiency, enhance process understanding and quality, advance cell culture and upstream processing, streamline recovery and purification, and optimize the quality and novelty of your next-generation biologic drug products. To…
Scale-Up of Single-Use Depth Filtration Systems
Process development engineers are responsible for developing scale-up strategies for efficient and cost-effective manufacture of biological and bioprocess-derived products at bench-scale, pilot scale and at manufacturing scale. A central unit operation in the production of these various therapeutic proteins is cell clarification using depth filtration. Recently, single-use depth filtration technologies have been developed, at scales ranging from the lab, to R&D, process development and on to manufacturing.
In this educational webcast, Laura Brown, Scientific Application Support Specialist II with 3M Purification, will provide guidelines for scaling-up of single-use depth filtration systems, and will review the commonly used single-use depth filtration products used for biopharmaceutical manufacturing.
BioSimilars and Biomanufacturing Briefing
Speakers: Karin Lucas Director, Training & Education BioTech Primer, Inc Timothy Fawcett Scientific Director BioTechnical Institute of Maryland, Inc. Listen to the audio cast here
Economic Impact of Single-Use Bioreactors
In order to match the improved titers and yield Innovation has provided, many biopharmaceutical companies are re-evaluating the operational costs of stainless steel and exploring the economics of single-use systems.
BioSimilars Have Arrived: Perspectives on the Path Forward
While the Biosimilar market is expected to reach $20B by 2020, four factors will play a major influence on just how quickly the biosimilar market will grow: patent expirations, regulatory pathways, development challenges and viability of a commercial model.
ROUNDTABLE – Single-Use Technologies: Industrialization, Standardization, Regulation – Common Goals and Differing Expectations
As the adoption and maturation of single-use technologies continues to evolve, many end-users are looking for single-use suppliers to standardize products, materials, and equipment in order to improve efficiency and lower costs. An expert group of industry suppliers discusses the pros/cons and differing expectation surrounding this trend.